Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented?

被引:64
作者
Cuculi, F. [1 ]
Lim, C. C. S. [1 ]
Banning, A. P. [1 ]
机构
[1] Oxford Radcliffe Hosp, Dept Cardiol, Oxford, England
关键词
CREATINE-KINASE-MB; INTRACORONARY BETA-BLOCKER; STATIN THERAPY; UNFRACTIONATED HEPARIN; UNIVERSAL DEFINITION; RANDOMIZED-TRIAL; CLINICAL-TRIAL; TROPONIN-T; CLOPIDOGREL PRETREATMENT; ANTIPLATELET THERAPY;
D O I
10.1136/hrt.2009.186189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Periprocedural myocardial injury (PMI) is common after percutaneous coronary intervention (PCI). Periprocedural infarction (myocardial infarction type 4a) occurs after at least 10% of PCI procedures and has an impact on long-term prognosis. Measurement of biomarkers to allow assessment of PMI is an important tool for clinical and research purposes and should be routine after every PCI (troponin I or T and CK-MB). The importance of oral and intravenous antiplatelet agents and other drugs which have been proven to reduce PMI is discussed.
引用
收藏
页码:736 / 740
页数:5
相关论文
共 66 条
[1]   Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions [J].
Abdelmeguid, AE ;
Topol, EJ ;
Whitlow, PL ;
Sapp, SK ;
Ellis, SG .
CIRCULATION, 1996, 94 (07) :1528-1536
[2]  
[Anonymous], N ENGL J MED
[3]   Effect of Intracoronary Nicardipine on Cardiac Enzymes After Elective Percutaneous Coronary Intervention [J].
Arora, Sandeep ;
Alfayoumi, Facli ;
Khawaja, Azimuddin Tareq ;
Dua, Aashish ;
Srinivasan, Venkatraman ;
Gradman, Alan H. .
CLINICAL CARDIOLOGY, 2009, 32 (06) :315-320
[4]   ASPIRIN AND DIPYRIDAMOLE IN THE PREVENTION OF ACUTE CORONARY-THROMBOSIS COMPLICATING CORONARY ANGIOPLASTY [J].
BARNATHAN, ES ;
SCHWARTZ, JS ;
TAYLOR, L ;
LASKEY, WK ;
KLEAVELAND, JP ;
KUSSMAUL, WG ;
HIRSHFELD, JW .
CIRCULATION, 1987, 76 (01) :125-134
[5]   Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial) [J].
Bonz, AW ;
Lengenfelder, B ;
Strotmann, J ;
Held, S ;
Turschner, O ;
Harre, K ;
Wacker, C ;
Waller, C ;
Kochsiek, N ;
Meesmann, M ;
Neyses, L ;
Schanzenbächer, P ;
Ertl, G ;
Voelker, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (04) :662-668
[6]   Novel Approaches for Preventing or Limiting Events (Naples) II Trial Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction [J].
Briguori, Carlo ;
Visconti, Gabriella ;
Focaccio, Amelia ;
Golia, Bruno ;
Chieffo, Alaide ;
Castelli, Alfredo ;
Mussardo, Marco ;
Montorfano, Matteo ;
Ricciardelli, Bruno ;
Colombo, Antonio .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (23) :2157-2163
[7]   Myonecrosis after revascularization procedures [J].
Califf, RM ;
Abdelmeguid, AE ;
Kuntz, RE ;
Popma, JJ ;
Davidson, CJ ;
Cohen, EA ;
Kleiman, NS ;
Mahaffey, KW ;
Topol, EJ ;
Pepine, CJ ;
Lipicky, RJ ;
Granger, CB ;
Harrington, RA ;
Tardiff, BE ;
Crenshaw, BS ;
Bauman, RP ;
Zuckerman, BD ;
Chaitman, BR ;
Bittl, JA ;
Ohman, EM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) :241-251
[8]   The impact of statin treatment on presentation mode and early outcomes in acute coronary syndromes [J].
Cuculi, F. ;
Radovanovic, D. ;
Eberli, F. R. ;
Stauffer, J. C. ;
Bertel, O. ;
Erne, P. .
CARDIOLOGY, 2008, 109 (03) :156-162
[9]   Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders A Prospective, Randomized Study [J].
Cuisset, Thomas ;
Frere, Corinne ;
Quilici, Jacques ;
Morange, Pierre-Emmanuel ;
Mouret, Jean-Philippe ;
Bali, Laurent ;
Moro, Pierre-Julien ;
Lambert, Marc ;
Alessi, Marie-Christine ;
Bonnet, Jean Louis .
JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (06) :649-653
[10]   Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial [J].
Desmet, WJR ;
Dens, J ;
Coussement, P ;
Van de Werf, F .
HEART, 2002, 88 (03) :293-295